Pirjo Käkelä Selected Research

Pirjo Käkelä Research Topics

Disease

13	Obesity 11/2023 - 06/2010
11	Weight Loss (Weight Reduction) 12/2023 - 06/2010
10	Non-alcoholic Fatty Liver Disease 11/2023 - 03/2012
9	Inflammation (Inflammations) 11/2023 - 03/2012
5	Alcoholic Fatty Liver 11/2023 - 03/2012
4	Fatty Liver 12/2018 - 02/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016 - 09/2013
3	Hyperglycemia 11/2023 - 11/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2012
3	Fibrosis (Cirrhosis) 01/2016 - 12/2014
2	Cholelithiasis 01/2017 - 07/2014
2	Liver Diseases (Liver Disease) 05/2016 - 09/2013
1	Internal Hernia 12/2023
1	Ventral Hernia 10/2022
1	Hernia (Hernias) 10/2022
1	Osteoarthritis 01/2018
1	Neoplasms (Cancer) 01/2017
1	Atherosclerosis 02/2015
1	Myocardial Infarction 02/2015
1	Hemorrhage 07/2014
1	Gallstones (Gallstone) 07/2014
1	Hyperinsulinism (Hyperinsulinemia) 11/2012
1	Insulin Resistance 03/2012
1	Morbid Obesity 06/2010

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 01/2018 - 03/2012
5	Fatty Acids (Saturated Fatty Acids)IBA 11/2023 - 11/2012
5	CholesterolIBA 01/2018 - 06/2010
4	Insulin (Novolin)FDA Link 11/2023 - 11/2012
4	Triglycerides (Triacylglycerol)IBA 12/2018 - 12/2014
3	Alanine Transaminase (SGPT)IBA 12/2018 - 09/2013
3	LipidsIBA 12/2018 - 12/2014
2	Protons (Proton)IBA 11/2023 - 12/2014
2	Fatty Acid DesaturasesIBA 10/2022 - 01/2017
2	Lipoproteins (Lipoprotein)IBA 12/2018 - 12/2014
2	Phytosterols (Plant Sterols)IBA 01/2018 - 01/2017
2	gamma-sitosterol (beta-sitosterol)IBA 01/2018 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 07/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2012
2	EnzymesIBA 05/2016 - 01/2016
1	Linoleic Acid (Linoleate)IBA 10/2022
1	EicosanoidsIBA 10/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	SterolsIBA 01/2018
1	stigmastanolIBA 01/2018
1	ElementsIBA 01/2018
1	Monounsaturated Fatty AcidsIBA 01/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	campesterolIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 10/2016
1	Cholesterol Esters (Cholesteryl Esters)IBA 05/2016
1	InterleukinsIBA 01/2016
1	AcyltransferasesIBA 01/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2015
1	Ketone BodiesIBA 07/2015
1	KetonesIBA 07/2015
1	VLDL LipoproteinsIBA 02/2015
1	oxidized low density lipoproteinIBA 12/2014
1	RNA Splicing FactorsIBA 02/2014
1	CalcineurinIBA 11/2013
1	DesmosterolIBA 09/2013
1	Transcription Factors (Transcription Factor)IBA 11/2012
1	P-2 (P 2)IBA 03/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2012

Therapy/Procedure

7	Gastric Bypass (Roux-en-Y Gastric Bypass) 06/2021 - 06/2010
2	Bariatric Surgery 01/2018 - 02/2014
2	Laparoscopic Cholecystectomy 01/2017 - 12/2012
2	Caloric Restriction 10/2016 - 02/2014
1	Jejunoileal Bypass 12/2023
1	Herniorrhaphy 10/2022
1	Cholecystectomy 10/2022
1	Duration of Therapy 07/2014